Prevalence and risk factors of silent brain infarcts in patients with AF detected by 3T-MRI.

Aged Atrial Fibrillation / complications Brain Infarction / diagnostic imaging Humans Magnetic Resonance Imaging Prevalence Risk Factors Stroke / diagnostic imaging
Atrial fibrillation MRI Silent brain infarction Stroke

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 16 03 2020
accepted: 04 05 2020
revised: 01 05 2020
pubmed: 16 5 2020
medline: 22 6 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Silent brain infarcts (SBI), a finding on neuroimaging, are associated with higher risk of future stroke. Atrial Fibrillation (AF) has been previously identified as a cause of SBI. The aim of this study is to determine the prevalence of and risk factors for SBI in patients with AF and low-to-moderate embolic risk according to CHADS Patients with a history of AF based on medical records who scored 0-1 in the CHADS 66 of the initial 443 patients (14.9%) and 41 of the 349 patients with low risk according to CHA LA enlargement on echocardiogram was associated with SBI in patients with AF and low or moderate embolic risk according to CHADS

Sections du résumé

BACKGROUND BACKGROUND
Silent brain infarcts (SBI), a finding on neuroimaging, are associated with higher risk of future stroke. Atrial Fibrillation (AF) has been previously identified as a cause of SBI.
OBJECTIVES OBJECTIVE
The aim of this study is to determine the prevalence of and risk factors for SBI in patients with AF and low-to-moderate embolic risk according to CHADS
METHODS METHODS
Patients with a history of AF based on medical records who scored 0-1 in the CHADS
RESULTS RESULTS
66 of the initial 443 patients (14.9%) and 41 of the 349 patients with low risk according to CHA
CONCLUSIONS CONCLUSIONS
LA enlargement on echocardiogram was associated with SBI in patients with AF and low or moderate embolic risk according to CHADS

Identifiants

DOI: 10.1007/s00415-020-09887-0 PMID: 32410017
pubmed: 32410017
doi: 10.1007/s00415-020-09887-0
pii: 10.1007/s00415-020-09887-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2675-2682

Subventions

Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España (ES)
ID : RTC-2016-5300-1
Organisme : Consejería de Salud, Junta de Andalucía
ID : PIN-0144-2016
Organisme : Spanish Neurovascular Disease Research Network
ID : (INVICTUS+, RD16/0019/0015

Auteurs

Irene Escudero-Martínez (I)

Department of Neurology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.
ORCID: 0000-0003-1838-0235

Rafael F Ocete (RF)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.
Department of Radiology, Hospital Universitario Virgen del Rocío, Seville, Spain.

Fernando Mancha (F)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

Ángela Vega (Á)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

Pilar Piñero (P)

Department of Radiology, Hospital Universitario Virgen del Rocío, Seville, Spain.

Antonio López-Rueda (A)

Department of Radiology, Hospital Clínic, Barcelona, Spain.

Elena Fajardo (E)

Department of Radiology, Hospital Universitario Virgen del Rocío, Seville, Spain.

Pilar Algaba (P)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

José Román Fernández-Engo (JR)

IT Department, Andalusian Healthcare System, Seville, Spain.

Eva M Martín-Sánchez (EM)

Information Systems Coordination Service, Andalusian Healthcare System, Seville, Spain.

Alejandro Galvao-Carmona (A)

Department of Psychology, Universidad Loyola Andalucía, Seville, Spain.

Elena Zapata-Arriaza (E)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.
Department of Radiology, Hospital Universitario Virgen del Rocío, Seville, Spain.

Lucía Lebrato (L)

Department of Neurology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

Blanca Pardo-Galiana (B)

Department of Neurology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

Juan Antonio Cabezas (JA)

Department of Neurology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

María Irene Ayuso (MI)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

Alejandro González (A)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.
Department of Radiology, Hospital Universitario Virgen del Rocío, Seville, Spain.

Francisco Moniche (F)

Department of Neurology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain.

Joan Montaner (J)

Neurovascular Research Group, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC, University of Seville, Av. Manuel Siurot s/n, 41013, Seville, Spain. jmontaner-ibis@us.es.
Department of Neurology, Hospital Universitario Virgen Macarena, Avenida Doctor Fedriani, No. 3, 41007, Seville, Spain. jmontaner-ibis@us.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Prevalence and risk factors of silent brain...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Fibrillation auriculaire › Prevalence and risk factors of silent brain...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Nécrose › Infarctus › Infarctus encéphalique › Prevalence and risk factors of silent brain...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prevalence and risk factors of silent brain...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Prevalence and risk factors of silent brain...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › Prevalence and risk factors of silent brain...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Prevalence and risk factors of silent brain...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Angiopathies intracrâniennes › Accident vasculaire cérébral › Prevalence and risk factors of silent brain...